Skip to main content

Recent advances on diagnosis and management of childhood asthma and food allergies


The epidemic of childhood allergic disorders has been associated to the decline of infectious disease. However, exposure to many triggers (airborne viruses, tobacco smoke, pollution, indoor allergens, etc.) contribute to the disease. Breast feeding practices, nutrition, dietary and obesity also play a multifaceted role in shaping the observed worldwide trends of childhood allergies. Guidelines for treatment are available, but their implementation is suboptimal. Then developed countries are slowing learning integrating the development of suitable guidelines with implementation plans. Awareness, psychosocial and family factors strongly influence asthma and food allergy control. Moreover, monitoring tools are necessary to facilitate self-management. By taking into consideration these and many other pragmatic aspects, national public health programs to control the allergic epidemic have been successful in reducing its impact and trace the need for future research in the area.

Allergy epidemic and the biodiversity hypothesis

Asthma and allergic rhinitis levels among children experienced a boost in the second half of the 20th century especially [1, 2] in developed countries, causing enormous burden for patients and societies [3]. However, the epidemiological heterogeneity at country level is great. In Iceland for example, a cohort of 179 children monitored for allergic manifestations for two decades showed a cumulative prevalence of 29% for asthma during the study period, with a peak prevalence of 28% at age of 4 years [4]. Similarly, the prevalence of asthma in Irish schoolchildren, aged 6–9 moved from 21.7% in 2002 to 23.5% in 2007 [5]. By contrast, in Belarus, in a cross-sectional study conducted in 2010 examined 2606 urban and 2422 rural children aged 6–16 years, the prevalence of asthma was as low as 3.84%. Symptoms of hay fever were also astonishingly rare (2.45%), when compared to the prevalence registered in the rest of Europe [6]. In parallel, dramatic increase of food allergies in the recent 15 yrs released a second wave of the allergic epidemic; however causing factors are still uncertain. In Australia for example, 10% of all infants suffer from a confirmed, IgE-mediated food allergy [7]. Many putative factors were here nominated, such as increased consumption (e.g. seafood allergies) [8], progressive urbanization [7], environmental factors and increased atopic disorders of the parents [911] or the increase in sensitization to pollen allergens (e.g. profilins, Bet v 1 and other PR-10 molecules, lipid transfer proteins) which cause the oral allergy syndrome [12]. A recent study on 3800 Finnish children demonstrated how children of allergic parents had a 2-fold higher risk to be sensitized/allergic to food if one and 3-fold risk if both parents suffered from any allergic manifestation [13]. On individual level, other factors including severe atopic eczema, maternal anti-helminthic therapy during pregnancy, birth season and order were suggested to affect the risk of food allergy outbreak in childhood [9, 1416]. For example, children born in autumn/winter had significantly a higher rate of food allergies compared with children born in spring/summer according to recent studies on 835 Australian and 1177 Korean children separately [11, 15]. Birth order was inversely related to the risk of food allergy and eczema [16].

Although infections are risk factors of chronic urticaria [17] and other allergic diseases, hygiene and anti-infectious treatments contribute to explain the raising trend of asthma and allergies and they can act even before birth. Maternal anti-helminthic therapy, while protecting the fetus from helminth infection, may facilitate allergy as suggested by a randomized, DBPC study with albendazole on more than 2500 Ugandan women. In this trial, a positive relation between mother’s treatment and increased risk for wheezing and eczema in infancy was found [14]. Gram negative bacteria have been the first category of infectious agents believed to protect from asthma and allergies. The Dutch WHISTLER-birth cohort has recently found that exposure to endotoxin in the first two months of life, in combination with house dust mite and cat allergens, is associated with an increase in the neonatal respiratory compliance. The authors concluded that endotoxin may contribute to the development of a normal lung function and maturity [18]. Not only bacteria, but also some viruses may protect of atopy. In American children up to 8 yrs of age, wild-type varicella zoster infection is associated with less atopic dermatitis (AD) and asthma, a phenomenon explained by suppression of IgE production and allergic sensitization and modified leukocyte subsets [19]. Under the hygiene hypothesis, the so-called “farming effect” is by far the most investigated epidemiological model. A meta-analysis of 39 studies showed a 25% lower asthma prevalence among subjects exposed to farming environment compared with unexposed subjects [20]. However, the basis of a protective effect of farming environment is still not sufficient understood. As proposed in the late nineties, a high microbial turnover at mucosal surfaces and a broad spectrum of microbial contacts in the every-day life may be at the basis of the atopy protecting effect of a traditional lifestyle [21, 22] also by exerting an influence at the level of GALT [23, 24]. This branch of the hygiene hypothesis, which may be defined as the “biodiversity” hypothesis, has been later supported by studies showing that the diversity of microbial flora early in life is protecting from atopic eczema [25, 26] and that the diversity of exposure to bacteria or fungi is an atopy protecting factor in farming children [27]. Accordingly, a cross-sectional study of almost 300 German children has shown that the sole ingestion of the farming milk is linked to less asthma by an increase in T-regulatory cells levels [28]. Similarly, local and systemic immune responses of piglets nursed by their mother on a commercial farm differ from those of isolated piglets fed with formula in a “clean” environment and display stronger regulatory components at mucosa level (CD4(+) CD25(+) Foxp3(+) regulatory T-cell) and higher IgG levels to food proteins at weaning [29]. A low-grade (or the so-called “minimal persistent”) inflammation induced by a farming environment in early childhood may protect against allergic diseases. In 653 children from the PASTURE birth cohort, those with undetectable high sensitive CRP (hsCRP) had increased prevalence of sensitization to inhaled and seasonal allergens [30]. However, the farming environment is showing a wheeze-protective effect also independently from atopy, for example by modifying the susceptibility to wheeze during viral infections [31].

The role of atopic sensitization and viral infections in asthma has been extensively reviewed [32] and investigated [33]. An open question remains the sequential relationship between these two components. A longitudinal study on 285 American children with high risk for allergic diseases and asthma demonstrated that sensitization to aeroallergens increases the risk of wheezing caused by HRV (but not by respiratory syncytial virus). In contrast, viral wheeze did not increase the risk for subsequent allergic sensitization. This study’s conclusion was that allergic sensitization is the one who precedes and might promote viral caused wheezing, and not the other way round [34]. However, other infections are also associated with asthma development. The ISAAC-Phase Two study found that pertussis and measles are associated with symptoms of asthma, rhinoconjunctivitis and eczema in schoolchildren aged 8–12 years, independently from IgE responses [35]. As a part of the same study, an investigation among more than 23,900 schoolchildren aged 8–12 years showed that tuberculosis was associated with asthma, hay fever and eczema symptoms, but not to immunization with BCG [36]. In Latin America not only helminthic infections [37] but a broad set of infections interfere with asthma and its atopic background. By contrast, in 1128 urban children from Salvador-Brazil tested to the 8 most common local pathogens those with 3 or fewer infection markers showed a higher prevalence of sIgE and SPT reactivity compared with those with 4 or more infection markers, but no association of these markers to asthma could be established [38]. The heterogeneity of the conclusions reached by different studies highlights the need of large international studies designed to increase sample heterogeneity and evaluation of local factors to minimize their confounding influence. Anyhow, early prevention is now necessary to avoid further progression of the allergy epidemic. Therefore, screening tests should be optimized to devise appropriate and economic national prevention and treatment strategies [9, 39].

Guidelines for treatment are available, but their implementation is suboptimal. Then developed countries are slowing learning integrating the development of suitable guidelines with implementation plans. Awareness, psychosocial and family factors strongly influence asthma and food allergy control. Moreover, monitoring tools are necessary to facilitate self-management. By taking into consideration these and many other pragmatic aspects, national public health programs to control the allergic epidemic have been successful in reducing its impact and trace the need for future research in the area.

Pollution and tobacco smoke

Traffic-related air pollution (TRAP) and biomass fuels (BMF) play a central role in the asthma epidemic especially in middle and low income countries. In Asia, TRAP and BMF increase the risk of asthma outbreaks, asthma exacerbations, respiratory infections and even COPD [40]. But also in a high income country, such as Canada, the frequency and duration of asthma exacerbations were associated with the levels of air pollution [41]. Domestic usage of BMF for fire, especially in low-income countries, is strongly associated with asthma and other lower respiratory diseases. Raising awareness at community level about this problem can reduce the negative impact caused by BMF [42]. In parallel, campaigns and legislations against tobacco smoke must be reinforced in high income countries, where this risk factor has not been yet defeated. Indeed, the ISAAC-Phase Three study among Maltese children demonstrated that passive and active tobacco smoke, that still is a frequent factor in that country, increased the risk of wheezing, exercise-induced wheezing, asthma, and rhinitis [43]. Furthermore, passive tobacco smoke’s influence is even stronger when it interacts with other risk factors, such as atopic sensitization. Among 486 children from the CCAAPS birth cohort, lung function was impaired at the ages 2, 4 and 7 years in atopic polysensitized girls exposed to tobacco smoke [44]. The effect of tobacco smoke seems to be partially affected also by genetic predisposition. Studies in the Norwegian ECA- and GAIN-cohorts have found that CHRNA3/5 polymorphisms on chromosome 15 are positively associated with bronchial hyperresponsiveness, especially in children exposed to tobacco smoke, no matter if set out in-utero or indoor at 10 yrs of age [45]. Similarly, among 157 children of the ECA-birth cohort, the impact of tobacco smoke exposure and pet keeping on allergy was conditioned by a limitation of CD14 methylation levels in exposed subjects [46]. All these data reinforce the concept that tobacco smoke must be contrasted at population level but also that risk factors of susceptibility must be taken into account at individual level.

Obesity, physical exercise and nutrition

The asthma epidemic is not the only one among children of developed and developing countries. A parallel increase in obesity and asthma rates suggests that allergic respiratory disease may be linked to dietary factors and behaviors and that the two conditions may influence each other [47]. Accordingly, a cross-sectional questionnaire-based survey in almost 34,700 Japanese children aged 4–5 years demonstrated how important obesity is in asthma management; current asthma was significantly more prevalent in overweight children compared with underweight and normal weight children after adjusting for other variables, such as gender, other coexisting allergic diseases, and parental history of asthma [48]. Weight reduction has been associated with variations of leptin, ghrelin and obestatin blood concentrations [49] thus correction of obesity implies changes of adipokines supposed to influence allergic inflammation.

The epidemic of childhood allergic disorders has been associated to the decline of infectious disease. However, exposure to many triggers (airborne viruses, tobacco smoke, pollution, indoor allergens, etc.) contribute to the disease. Breast feeding practices, nutrition, dietary and obesity also play a multifaceted role in shaping the observed worldwide trends of childhood allergies.

A smaller study among Italian children has shown that the female gender is a risk factor for asthma associated to obesity [50]. Regular physical exercise may even induce beneficial immune system responses and reduce pro-inflammatory cytokines secretion [51]. In this respect, the positive influence of sport on asthma encourages physical activity in asthmatic children who are obese or overweight [51]. Nevertheless, physical can play a role on FEIA and anaphylaxis [52], hence only physical activities that are well tolerated should be promoted in at risk asthmatic patients.

The impact of nutrition on the development of respiratory disorders in childhood may begin already before birth. In a Finnish population-based birth cohort study (n = 2441), mother’s reduced intake of certain foods (leafy vegetables, malaceous fruits, certain fatty acids and chocolate) during pregnancy was associated with increased risk of wheeze (but not asthma) in her child at 5 years of age [53, 54]. However, ‘Western-Diet” including a higher intake of meat, eggs, vegetables’ oil and white vegetables was linked to a reduce risk of wheezing among children aged 16–24 Months [55]. The intake of vitamin D is also increasingly investigated in this area. In an experimental mouse model, vitamin D deficiency in utero was found associated with enhanced allergen-induced lymphocyte responses and cytokine production into airways [56]. A case–control study of children with severe therapy-resistant asthma, moderate asthma and healthy controls demonstrated that patients with severe therapy-resistant asthma have significantly lower levels of vitamin D. Decreased levels were also associated with increased airways smooth muscle mass, worse asthma control and lung function [57]. Vitamin D levels may also explain seasonal variations in food allergies risk [15]. Moreover, nutritional deficits have been linked to food allergies [9, 58] and supplementary nutrients have been proposed. A recent case–control study on 191 French children (mean age 4 yrs) showed that food allergic patients are smaller than healthy controls [59]. On the other hand, extensive nutrition restrictions in food allergic children are not always necessary and should be established on a case by case fashion, as demonstrated by a recent study on 145 British peanut allergic children [60]. Last but not least, the impact of breastfeeding on asthma and food allergy still remains a hotly debated topic. A longitudinal study on 882 Australian and Swedish children with parental wheeze or asthma found a lower risk for developing asthma at age 4 and 8 yrs among breast-fed, compared to bottle-fed children. Furthermore, breast-feeding did not influence the sensitization rate to airborne allergens but it was a risk factor for sensitization to cow’s milk, peanuts and eggs [61]. Similarly, prolonged breastfeeding and delayed introduction of solid food provided no evidence to be protective from atopic eczema in a population of over 18,700 Taiwan infants [62].

Prediction and prevention

Suitable and reliable prediction tools are essential to identify targets for prevention. Since many years clinical scientists are trying to find markers predicting asthma. A recent study has shown that inflammatory markers, including many interleukins (IL-2, IL-4, IL-8 and IL-10) are elevated in the exhaled breath condensate already during the pre-clinical phase anticipating wheezing [63]. Furthermore, perinatal factors may affect lung maturity and contribute to cause wheezing and asthma. Neonatal jaundice, for example, increased the risk of asthma in the first six years of life among Taiwanese neonates [64]. Atopic sensitization in infancy has been often used as a predictor of atopic diseases at school age. Recently, Item Response Theory (IRT) models, have been applied to SPT results at 2 years of age to predict persistent wheeze, rhino-conjunctivitis, and eczema at age 4 and to identify the allergens most associated with atopy predisposition [65].

Prediction models are used to facilitate the identification of targets for prevention. Until a few years ago, allergic asthma prevention has been mostly based on allergen avoidance. Studies results though show no or little benefit from allergen avoidance. By contrast, a national plan for allergy and asthma prevention, recently implemented in Finland, has shown that implementation of balanced diets, physical activity and protection from other allergy promoting factors such as tobacco smoke represent adequate prevention methods [66]. This Finnish program was then based on a multifaceted strategy. The complexity of the immune response and of allergy pathogenesis is making more and more questionable if one kind of intervention alone is sufficient to prevent allergic disease in high risk children. More and more relevance is being given to the concept of a poly-factorial intervention, based on both, avoiding risk factors and providing protective factors. Unfortunately, the feasibility of interventions in everyday life declines with their increasing complexity [6668]. For example, a study on 476 Dutch children demonstrated that PREVASC multifaceted intervention was efficient in reducing the exposure to inhalant and food allergens. Nevertheless, this program was unable to reduce the prevalence of asthma at the age of 6 yrs, as the parents were unable to properly implement all the measures of this complex prevention plan [69].

In contrast to asthma, studies on prediction and prevention of atopic eczema are still providing relatively conflicting outcomes. However, the “classical” biomarkers of allergy, such as total and specific IgE levels are still considered valuable pre-clinical predictive biomarkers [7073]. For example, elevated maternal IgE levels during pregnancy were associated in non-atopic mothers to increased risk of eczema in offspring [70]. Elevated cord blood IgE, together with specific LT-α and FcϵRI-β genotypes and a higher maternal stress during pregnancy were linked to a higher risk of eczema at age of 2 yrs [71]. Similarly, not SPT [72] but IgE levels can be useful in predicting a positive food challenge test [73]. Although these biomarkers can help predicting atopic eczema [74], prevention is unfortunately still difficult. Probiotics are widely marketed as useful against food allergy [75, 76], respiratory infections [77] and airway inflammation [78], but their preventive efficacy has not been confirmed. For example, Lactobacillus rhamnosus GG, given to the mother during pregnancy, had no influence on her child’s gut colonization profile [79] and their content in cow’s milk and egg’s white proteins may be even dangerous for allergic patients [80]. However, supplementation of the probiotic Lactobacillus plantarum CJLP133 provided beneficial results in the treatment of pediatric AD in a case–control study on 88 Korean children between 12 months and 13 yrs [81].

Monitoring and control

Asthma control is essential to prevent long-term consequences of asthma and improve patients’ quality of life. Hence, many studies focus on identification of reliable diagnostic tools to monitor asthma control. While the diagnostic role of atopic tests, lung function and challenge tests in asthma are quite established since decades that of breath condensate is still hotly debated. Exhaled nitric oxide (NO), a non-invasive marker of airway inflammation, can be implemented in the diagnosis and management of asthma and its strong relation to atopy, (e.g. house dust mite sensitization) has been recently described [82]. Furthermore, elevated bronchial NO output is associated with an increased risk of exercise-induced bronchoconstriction in atopic patients during childhood and adolescence [51]. Similarly, fractional exhaled NO (FeNO) was also elevated in the sputum of asthmatics with coexisting food allergy suggesting an association of asthma with food allergies through an increased eosinophilic inflammation [83]. Accordingly, in 467 children from the European Community Respiratory Health Survey II, FeNO was only elevated in asthmatic patient with simultaneous sensitization to food and pollen allergens [84]. Unfortunately, FeNO levels in exhaled breath may be not always appropriate as a marker to monitor asthma control over time [85]. This has been also confirmed by a study showing a poor accuracy to discriminate well- from not well-controlled asthma in a case–control study among 664 Dutch children aged 4–12 yrs [86].

Other measures of oxidative stress have been also tested. A case–control study on 219 Turkish children has shown that higher concentrations of Malondialdehyde and GSH in exhaled breath condensate are a marker of asthma and allergic rhinitis and are associated with enhanced oxidative stress [87]. Another case–control study among 22 asthmatic Swedish children (6–18 years) demonstrated the relevance of basophil allergen threshold sensitivity (also CD-sens) in identifying those with the most severe and uncontrolled allergic asthma [88]. Last, clinical indexes are also intensively investigated, as they can allow daily monitoring. The visual analogue scale (VAS), a widespread assessment in Pediatrics, confirmed its usefulness in measuring breathlessness perception in Italian asthmatic children and was significantly related to lung function [89]. However, other clinic assessments lack so far of unsatisfying accuracy and reliability levels. A study in 314 patients has recently shown that both, GINA-guided and C-ACT-guided (Childhood-Asthma Control Test) assessment have a poor accuracy and reliability in measuring the level of asthma control, if used separately [90].

Anti-inflammatory drugs and bronchodilators [9193] and antibiotics (e.g. macrolides) [94] help controlling asthma but allergen-specific immunotherapy (SIT) is the only treatment potentially changing the natural history of the allergic component of moderate asthma, with a potential long lasting exacerbation-preventing effect and corticosteroid-sparing effect [95]. However, due to the difficulty in carrying out placebo controlled trials, efficacy of SIT, especially in its subcutaneous version (SCIT), has been so far demonstrated in children by a few trials only [9698].

Food allergy monitoring and control is a highly developing area of investigation and we can consider here only a few examples of studies dealing with the need of molecular diagnosis, the antigen-specificity of oral tolerance induction and the use of epinephrine, respectively.

Cross-reactivity and pan-allergens represent one of the difficulties that often hamper the diagnosis of allergies to vegetal food in childhood. Therefore, diagnostic tools should be developed to support clinicians in distinguishing between tolerant and allergic and then between primary and secondary allergic patients. In birch-pollen-associated secondary soy allergy, SPT with soy flour and molecular diagnostic of specific IgE to Gly m4 facilitate a correct diagnosis [99]. IgE levels to seed storage proteins Ara h1, Ara h2 and Ara h3 allow distinguishing peanut-allergic from tolerant patients [100, 101]. By contrast, peanut-specific IgG or IgG4 levels were elevated in peanut-sensitized children and did not indicate tolerance or protection from sensitization as observed in other atopic diseases [102]. Similar findings were also shown in patients with egg allergy, where elevated levels of specific IgG to ovalbumin, β-lactoglobulin and α-casein were associated with positive SPT to egg. In contrary, elevated IgG4 levels to α-casein was linked to a negative DBPC cow’s milk challenge [103]. On the other hand, cytokines and other immunological markers are being investigated for a more precise monitoring of food allergies. For example, the interleukin IL-21 may be involved in the pathogenesis of atopic dermatitis [104] and the chemokine CCL18, also known as pulmonary and activation-regulated chemokine (PARC), may be linked to disease severity [105].

Studies on oral tolerance induction (OIT) are defining more and more the usefulness and limitations of this novel therapeutic approach. Cow’s milk allergy affects 1.9-4.9% of the children, of which a few might suffer from a protein energy malnutrition caused by the subsequent dietary [106]. Therefore, oral tolerance induction provides a chance for these patients to avoid possible late-implication caused by dietary restrictions such as growth impairment. Recent studies on SOTI demonstrated an increase of regulatory cells such as Foxp3+ regulatory T-cells and other hypo-proliferative subset of T-cells (CD4+, CD38+ and CD45RO-) which characterize tolerance development, suggesting possible pathways for tolerance induction in cow’s milk and hen’s egg allergic patients [107, 108]. The induction of clinical tolerance, however, is antigen specific. This aspect is essential from a clinical stand point, as many children with cow’s milk allergy react also to goat’s or sheep’s milk. Unfortunately, orally induced tolerance to cow’s milk does not protect these children from reactions to the milk of other mammals [109, 110] and elimination diets are sometime not sufficient to avoid severe reactions in allergic children [111]. A few children with severe food allergies cannot be treated with SOTI, as they do not tolerate even minute amount of the relevant allergen. In these children, proper education, availability and correct use of epinephrine is often essential. Unfortunately this is not always the case. A recent investigation of 1361 adverse reactions to food in the US showed that only one third of the reactions requiring intervention with epinephrine were correctly managed [58]. Actually, guidelines on anaphylaxis are not sufficiently implemented although they are distributed to most pediatricians [112]. Education and awareness about anaphylaxis is therefore still insufficient to guarantee guidelines implementation and the guidelines themselves should be perhaps simplified and made more user-friendly [113].

Psychological and public health aspects

Despite intensive research and progress, allergic diseases in childhood still represent a complex challenge for the family and the society. They has a considerable impact on quality of life for the patients and a financial burden for the society caused by increased costs, morbidity and mortality [114]. A recent meta-analysis considering almost 3550 children with asthma has shown that patients suffer from more depression and anxiety, independently from the level of severity of their asthma [115]. Similarly, among the asthmatic adults screened in the Asthma Insight and Management (AIM) survey in the United States, patients rated their health as “only fair,” “poor,” or “very poor,” or experienced limitations in activity because of health problems, compared with the general population. This indicates that the burden of asthma remains high in the US despite the availability of updated treatment guidelines and new therapies [116]. Moreover, severe reactions observed in food allergies have also immense impact on patients’ quality of life. A recent survey on the life quality of food allergic children showed that patients who experienced severe systemic reactions, with multiple food allergies or with siblings/mother affected by allergies score worse in quality of life questionnaire [117]. In this respect, it is interesting to note that a farming environment, which in somehow implies a healthier contact with nature, can influence not only physical and objective reactions but also the psychological well-being of allergic and asthmatic patients [118].

Hence, not only for the patients, but also for their families it is important to establish clear plans beyond the patient’s direct needs by involving the community. Such perspectives can be successfully achieved by national-wide management programs aimed at minimizing disease’s impact on the whole society and the healthcare systems [66]. Further inputs provided by parents and/or patients associations might be useful. A management curriculum for the parents of newly diagnosed food allergic children can reduce both stress and anxiety and improve the quality of life of the allergic children and their parents [119].

Guidelines for treatment are available, but their implementation is suboptimal. Developed countries are slowing learning integrating the development of suitable guidelines with implementation plans. Awareness, psychosocial and family factors strongly influence asthma and food allergy control. Moreover, monitoring tools are necessary to facilitate self-management. By taking into consideration these and many other pragmatic aspects, national public health programs to control the allergic epidemic have been successful in reducing its impact and trace the need for future research in the area.

Moreover, awareness for food allergies and anaphylaxis must be improved also among teachers and school-personnel, since schools are the places with the highest attack-related death rate [120]. Recommendations must not only guide diagnosis and treatment, but should also prevent unjustified and exaggerated allergen avoidance, which heavily affect life quality and immunologic tolerance development. This is true not only for food, but also for respiratory allergies. Accordingly, asthma control programs have to be made easy and integrated into everyday life. An authentic reflection of the difficulties facing implementation of asthma control programs in real life has been shown by the results of the CHOICE survey on 1000 American asthmatic patients. Almost the half of the patients did not use controller medications while 80% of those had a persistent asthma. Moreover, only 14.3% of patients on controllers were well controlled [121]. Other studies reported high levels of over- and under-treatment for asthma [122, 123]. Hence, despite updated guidelines, the large offer in medication and active national management programs, control programs are still not well implemented in “real life”. Old guidelines included also unnecessary recommendations: for example, pet avoidance has been a long-lasting prescription for asthma prevention. Recent studies have confirmed that pet exposure in early life is not to be suspended even in families with “at risk” atopic/allergic children, unless pet already cause symptoms [124]. Guidelines should be therefore “user friendly”, so that GPs, parents, health care centers and schools can easily learn how to handle asthma without useless restriction or even harming influences for the affected children. This has been confirmed by a recent study on 170 Dutch children, where parental concerns about adverse consequences of the medication and low maternal education were associated with uncontrolled asthma [125]. Attention to guidelines feasibility has probably greatly contributed to the success of the Finnish plan for asthma control [66]. The Finnish experience can therefore encourage other countries to in their attempt to revert the epidemic trend of asthma and allergies or at least to control better the social impact of this childhood chronic disease.


The most recent advances in the field of childhood asthma summarized in this review give us an idea of how fast clinical research in this area is making progress. Solid approaches to avoid risk factors and to promote protective factors should be established according to the recent findings. Nevertheless, many studies demonstrated the huge lack in adopting and implementing recommendations and guidelines in everyday life, which require further development of current intervention and control strategies in the framework of national asthma control programs to choke the worldwide asthma epidemic.



Allergic rhinitis


Body mass index


Confidence interval


Double blinded placebo controlled


Global initiative for asthma


House dust mites


Human rhinovirus


International study of asthma and allergies in childhood


Odds ratio


Polycyclic aromatic hydrocarbons


Fine particular matter


Respiratory syncytial virus


Subcutaneous specific immunotherapy


Sublingual specific immunotherapy


Specific oral tolerance induction


Skin prick test




  1. 1.

    Strachan D, Sibbald B, Weiland S, Aït-Khaled N, Anabwani G, Anderson HR, et al.: Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the international study of asthma and allergies in childhood (ISAAC). Pediatr Allergy Immunol. 1997, 8: 161-176. 10.1111/j.1399-3038.1997.tb00156.x.

    CAS  PubMed  Google Scholar 

  2. 2.

    Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, et al.: ISAAC phase three study group: worldwide trends in the prevalence of asthma symptoms: phase III of the international study of asthma and allergies in childhood (ISAAC). Thorax. 2007, 62: 758-766. 10.1136/thx.2006.070169.

    PubMed Central  PubMed  Google Scholar 

  3. 3.

    Meltzer EO, Blaiss MS, Derebery MJ, Mahr TA, Gordon BR, Sheth KK, et al.: Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol. 2009, 124 (3 Suppl): S43-S70.

    PubMed  Google Scholar 

  4. 4.

    Finnbogadóttir AF, Árdal B, Eiríksson H, Hrafnkelsson B, Valdimarsson H, Lúðvíksson BR, et al.: A long-term follow-up of allergic diseases in Iceland. Pediatr Allergy Immunol. 2012, 23: 181-185. 10.1111/j.1399-3038.2011.01234.x.

    PubMed  Google Scholar 

  5. 5.

    Duggan EM, Sturley J, Fitzgerald AP, Perry IJ, Hourihane JO: The 2002–2007 trends of prevalence of asthma, allergic rhinitis and eczema in Irish schoolchildren. Pediatr Allergy Immunol. 2012, 23: 464-471. 10.1111/j.1399-3038.2012.01291.x.

    PubMed  Google Scholar 

  6. 6.

    Shpakou A, Brożek G, Stryzhak A, Neviartovich T, Zejda J: Allergic diseases and respiratory symptoms in urban and rural children in Grodno Region (Belarus). Pediatr Allergy Immunol. 2012, 23: 339-346. 10.1111/j.1399-3038.2011.01263.x.

    PubMed  Google Scholar 

  7. 7.

    Prescott S, Allen KJ: Food allergy: riding the second wave of the allergy epidemic. Pediatr Allergy Immunol. 2011, 22: 155-160. 10.1111/j.1399-3038.2011.01145.x.

    PubMed  Google Scholar 

  8. 8.

    Tsabouri S, Triga M, Makris M, Kalogeromitros D, Church MK, Priftis KN: Fish and shellfish allergy in children: review of a persistent food allergy. Pediatr Allergy Immunol. 2012, 23: 608-615. 10.1111/j.1399-3038.2012.01275.x.

    PubMed  Google Scholar 

  9. 9.

    Santos AF, Lack G: Food allergy and anaphylaxis in pediatrics: update 2010–2012. Pediatr Allergy Immunol. 2012, 23: 698-706. 10.1111/pai.12025.

    PubMed  Google Scholar 

  10. 10.

    McBride D, Keil T, Grabenhenrich L, Dubakiene R, Drasutiene G, Fiocchi A, et al.: The EuroPrevall birth cohort study on food allergy: baseline characteristics of 12,000 newborns and their families from nine European countries. Pediatr Allergy Immunol. 2012, 23: 230-239. 10.1111/j.1399-3038.2011.01254.x.

    CAS  PubMed  Google Scholar 

  11. 11.

    Kim J, Chang E, Han Y, Ahn K, Lee SI: The incidence and risk factors of immediate type food allergy during the first year of life in Korean infants: a birth cohort study. Pediatr Allergy Immunol. 2011, 22: 715-719. 10.1111/j.1399-3038.2011.01163.x.

    PubMed  Google Scholar 

  12. 12.

    Dondi A, Tripodi S, Panetta V, Asero R, Businco AD, Bianchi A, et al.: Pollen-induced allergic rhinitis in 1360 Italian children: comorbidities and determinants of severity. Pediatr Allergy Immunol. 2013, in press

    Google Scholar 

  13. 13.

    Pyrhönen K, Hiltunen L, Kaila M, Näyhä S, Läärä E: Heredity of food allergies in an unselected child population: an epidemiological survey from Finland. Pediatr Allergy Immunol. 2011, 22: 124-132. 10.1111/j.1399-3038.2010.01095.x.

    Google Scholar 

  14. 14.

    Mpairwe H, Webb EL, Muhangi L, Ndibazza J, Akishule D, Nampijja M, et al.: Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised-controlled trial results. Pediatr Allergy Immunol. 2011, 22: 305-312. 10.1111/j.1399-3038.2010.01122.x.

    PubMed Central  PubMed  Google Scholar 

  15. 15.

    Mullins RJ, Clark S, Katelaris C, Smith V, Solley G, Camargo CA: Season of birth and childhood food allergy in Australia. Pediatr Allergy Immunol. 2011, 22: 583-589. 10.1111/j.1399-3038.2011.01151.x.

    PubMed  Google Scholar 

  16. 16.

    Kusunoki T, Mukaida K, Morimoto T, Sakuma M, Yasumi T, Nishikomori R, et al.: Birth order effect on childhood food allergy. Pediatr Allergy Immunol. 2012, 23: 250-254. 10.1111/j.1399-3038.2011.01246.x.

    PubMed  Google Scholar 

  17. 17.

    Caffarelli C, Cuomo B, Cardinale F, Barberi S, Dascola CP, Agostinis F, et al.: Aetiological factors associated with chronic urticarial in children: a systematic review. Acta Dermatol Venereol. 2013, 93: 268-272. 10.2340/00015555-1511.

    Google Scholar 

  18. 18.

    Abbing-Karahagopian V, van der Gugten AC, van der Ent CK, Uiterwaal C, de Jongh M, Oldenwening M, et al.: Effect of endotoxin and allergens on neonatal lung function and infancy respiratory symptoms and eczema. Pediatr Allergy Immunol. 2012, 23: 448-455. 10.1111/j.1399-3038.2012.01296.x.

    PubMed  Google Scholar 

  19. 19.

    Silverberg JI, Kleiman E, Silverberg NB, Durkin HG, Joks R, Smith-Norowitz TA: Chickenpox in childhood is associated with decreased atopic disorders, IgE, allergic sensitization, and leukocyte subsets. Pediatr Allergy Immunol. 2012, 23: 50-58. 10.1111/j.1399-3038.2011.01224.x.

    PubMed  Google Scholar 

  20. 20.

    Genuneit J: Exposure to farming environments in childhood and asthma and wheeze in rural populations: a systematic review with meta-analysis. Pediatr Allergy Immunol. 2012, 23: 509-518. 10.1111/j.1399-3038.2012.01312.x.

    PubMed  Google Scholar 

  21. 21.

    Rook GA, Stanford JL: Give us this day our daily germs. Immunol Today. 1998, 19: 113-116.

    CAS  PubMed  Google Scholar 

  22. 22.

    Matricardi PM, Bonini S: High microbial turnover rate preventing atopy: a solution to inconsistencies impinging on the hygiene hypothesis?. Clin Exp Allergy. 2000, 30: 1506-1510. 10.1046/j.1365-2222.2000.00994.x.

    CAS  PubMed  Google Scholar 

  23. 23.

    Wold AE: The hygiene hypothesis revised: is the rising frequency of allergy due to changes in the intestinal flora?. Allergy. 1998, 53: 20-25.

    CAS  PubMed  Google Scholar 

  24. 24.

    Matricardi PM, Rosmini F, Ferrigno L, Riondino S, Rapicetta M, Fortini M, et al.: Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: an epidemiological study. BMJ. 2000, 320: 412-417. 10.1136/bmj.320.7232.412.

    PubMed Central  CAS  PubMed  Google Scholar 

  25. 25.

    Wang M, Karlsson C, Olsson C, Adlerberth I, Wold AE, Strachan DP, et al.: Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol. 2008, 121: 129-134. 10.1016/j.jaci.2007.09.011.

    PubMed  Google Scholar 

  26. 26.

    Ismail IH, Oppedisano F, Joseph SJ, Boyle RJ, Licciardi PV, Robins-Browne RM, et al.: Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol. 2012, 23: 674-681. 10.1111/j.1399-3038.2012.01328.x.

    PubMed  Google Scholar 

  27. 27.

    Ege MJ, Mayer M, Normand AC, Genuneit J, Cookson WO, Braun-Fahrländer C: Exposure to environmental microorganisms and childhood asthma. N Engl J Med. 2011, 364: 701-709. 10.1056/NEJMoa1007302.

    CAS  PubMed  Google Scholar 

  28. 28.

    Lluis A, Depner M, Gaugler B, Saas P, Casaca VI, Raedler D, et al.: Increased regulatory T-cell numbers are associated with farm milk exposure and lower atopic sensitization and asthma in childhood. J Allergy Clin Immunol. 2013, doi: 10.1016/j.jaci.2013.06.034. [Epub ahead of print]

    Google Scholar 

  29. 29.

    Lewis MC, Inman CF, Patel D, Schmidt B, Mulder I, Miller B, et al.: Direct experimental evidence that early-life farm environment influences regulation of immune responses. Pediatr Allergy Immunol. 2012, 23: 265-269. 10.1111/j.1399-3038.2011.01258.x.

    PubMed  Google Scholar 

  30. 30.

    Mustonen K, Keski-Nisula L, Vaarala O, Pfefferle PI, Renz H, Riedler J, et al.: Few associations between high-sensitivity C-reactive protein and environmental factors in 4.5-year-old children. Pediatr Allergy Immunol. 2012, 23: 522-528. 10.1111/j.1399-3038.2012.01306.x.

    PubMed  Google Scholar 

  31. 31.

    Fuchs O, Genuneit J, Latzin P, Buchele G, Horak E, Loss G, et al.: Farming environments and childhood atopy, wheeze, lung function, and exhaled nitric oxide. J Allergy Clin Immunol. 2012, 130: 382-388. 10.1016/j.jaci.2012.04.049.

    CAS  PubMed  Google Scholar 

  32. 32.

    Holt PG, Sly PD: Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med. 2012, 18: 726-735. 10.1038/nm.2768.

    CAS  PubMed  Google Scholar 

  33. 33.

    Jartti T, Korppi M: Rhinovirus-induced bronchiolitis and asthma development. Pediatr Allergy Immunol. 2011, 22: 350-355. 10.1111/j.1399-3038.2011.01170.x.

    PubMed  Google Scholar 

  34. 34.

    Jackson DJ, Evans MD, Gangnon RD, Tisler CJ, Pappas TE, Lee WM, et al.: Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med. 2012, 185: 281-285. 10.1164/rccm.201104-0660OC.

    PubMed Central  PubMed  Google Scholar 

  35. 35.

    Nagel G, Weinmayr G, Flohr C, Kleiner A, Strachan DP, ISAAC phase two study group: Association of pertussis and measles infections and immunizations with asthma and allergic sensitization in ISAAC Phase Two. Pediatr Allergy Immunol. 2012, 23: 737-746.

    PubMed  Google Scholar 

  36. 36.

    Flohr C, Nagel G, Weinmayr G, Kleiner A, Williams HC, Aït-Khaled N, et al.: Tuberculosis, bacillus calmette-guérin vaccination, and allergic disease: findings from the international study of asthma and allergies in childhood phase two. Pediatr Allergy Immunol. 2012, 23: 324-331. 10.1111/j.1399-3038.2011.01248.x.

    PubMed  Google Scholar 

  37. 37.

    Vereecken K, Kanobana K, Wördemann M, Junco Diaz R, Menocal Heredia L, Ruiz Espinosa A, et al.: Associations between atopic markers in asthma and intestinal helminth infections in Cuban schoolchildren. Pediatr Allergy Immunol. 2012, 23: 332-338. 10.1111/j.1399-3038.2011.01267.x.

    PubMed  Google Scholar 

  38. 38.

    Alcantara-Neves NM, Veiga RV, Dattoli VC, Fiaccone RL, Esquivel R, Cruz ÁA, et al.: The effect of single and multiple infections on atopy and wheezing in children. J Allergy Clin Immunol. 2012, 129: 359-367. 10.1016/j.jaci.2011.09.015.

    PubMed  Google Scholar 

  39. 39.

    Pyrhönen K, Hiltunen L, Näyhä S, Läärä E, Kaila M: Real-life epidemiology of food allergy testing in Finnish children. Pediatr Allergy Immunol. 2011, 22: 361-368. 10.1111/j.1399-3038.2011.01140.x.

    PubMed  Google Scholar 

  40. 40.

    Leung TF, Ko FW, Wong GW: Roles of pollution in the prevalence and exacerbations of allergic diseases in Asia. J Allergy Clin Immunol. 2012, 129: 42-47. 10.1016/j.jaci.2011.11.031.

    CAS  PubMed  Google Scholar 

  41. 41.

    Cakmak S, Dales RE, Coates F: Does air pollution increase the effect of aeroallergens on hospitalization for asthma?. J Allergy Clin Immunol. 2012, 129: 228-231. 10.1016/j.jaci.2011.09.025.

    CAS  PubMed  Google Scholar 

  42. 42.

    Laumbach RJ, Kipen HM: Respiratory health effects of air pollution: update on biomass smoke and traffic pollution. J Allergy Clin Immunol. 2012, 129: 3-11. 10.1016/j.jaci.2011.11.021.

    PubMed Central  CAS  PubMed  Google Scholar 

  43. 43.

    Montefort S, Ellul P, Montefort M, Caruana S, Grech V, Agius MH: The effect of cigarette smoking on allergic conditions in Maltese children (ISAAC). Pediatr Allergy Immunol. 2012, 23: 472-478. 10.1111/j.1399-3038.2012.01276.x.

    PubMed  Google Scholar 

  44. 44.

    Brunst KJ, Ryan PH, Lockey JE, Bernstein DI, McKay RT, Khurana Hershey GK, et al.: Unraveling the relationship between aeroallergen sensitization, gender, second-hand smoke exposure, and impaired lung function. Pediatr Allergy Immunol. 2012, 23: 479-487. 10.1111/j.1399-3038.2012.01292.x.

    PubMed  Google Scholar 

  45. 45.

    Torjussen TM, Lødrup Carlsen KC, Munthe-Kaas MC, Mowinckel P, Carlsen KH, Helms PJ, et al.: Alpha-nicotinic acetylcholine receptor and tobacco smoke exposure: effects on bronchial hyperresponsiveness in children. Pediatr Allergy Immunol. 2012, 23: 40-49. 10.1111/j.1399-3038.2011.01222.x.

    PubMed  Google Scholar 

  46. 46.

    Munthe-Kaas MC, Bertelsen RJ, Torjussen TM, Hjorthaug HS, Undlien DE, Lyle R, et al.: Pet keeping and tobacco exposure influence CD14 methylation in childhood. Pediatr Allergy Immunol. 2012, 23: 747-754.

    PubMed  Google Scholar 

  47. 47.

    Jensen ME, Wood LG, Gibson PG: Obesity and childhood asthma - mechanisms and manifestations. Curr Opin Allergy Clin Immunol. 2012, 12: 186-192. 10.1097/ACI.0b013e3283508df5.

    PubMed  Google Scholar 

  48. 48.

    Okabe Y, Adachi Y, Itazawa T, Yoshida K, Ohya Y, Odajima H, et al.: Association between obesity and asthma in Japanese preschool children. Pediatr Allergy Immunol. 2012, 23: 550-555. 10.1111/j.1399-3038.2011.01261.x.

    PubMed  Google Scholar 

  49. 49.

    Arrigo T, Gitto E, Ferraú V, Munafò C, Alibrandi A, et al.: Effect of weight reduction on leptin, total ghrelin and obestatin concentrations in prepubertal children. J Biol Regul Hom Agents. 2012, 26: 95-103.

    Google Scholar 

  50. 50.

    Tosca MA, Silvestri M, Ciprandi G, Rossi GA: Obesity and asthma in Caucasian preschool children: is there a gender difference?. Pediatr Allergy Immunol. 2012, 23: 793-794. 10.1111/j.1399-3038.2012.01324.x.

    PubMed  Google Scholar 

  51. 51.

    Del Giacco SR, Carlsen KH, Du Toit G: Allergy and sports in children. Pediatr Allergy Immunol. 2012, 23: 11-20. 10.1111/j.1399-3038.2011.01256.x.

    PubMed  Google Scholar 

  52. 52.

    Povesi Dascola C, Caffarelli C: Exercise-induced anaphylaxis: a clinical view. It J Ped. 2012, 14: 38-43.

    Google Scholar 

  53. 53.

    Erkkola M, Nwaru BI, Kaila M, Kronberg-Kippilä C, Ilonen J, Simell O, et al.: Risk of asthma and allergic outcomes in the offspring in relation to maternal food consumption during pregnancy: a Finnish birth cohort study. Pediatr Allergy Immunol. 2012, 23: 186-194. 10.1111/j.1399-3038.2012.01272.x.

    PubMed  Google Scholar 

  54. 54.

    Lumia M, Luukkainen P, Tapanainen H, Kaila M, Erkkola M, Uusitalo L, et al.: Dietary fatty acid composition during pregnancy and the risk of asthma in the offspring. Pediatr Allergy Immunol. 2011, 22: 827-835. 10.1111/j.1399-3038.2011.01202.x.

    PubMed  Google Scholar 

  55. 55.

    Miyake Y, Okubo H, Sasaki S, Tanaka K, Hirota Y: Maternal dietary patterns during pregnancy and risk of wheeze and eczema in Japanese infants aged 16–24 months: the Osaka maternal and child health study. Pediatr Allergy Immunol. 2011, 22: 734-741. 10.1111/j.1399-3038.2011.01176.x.

    PubMed  Google Scholar 

  56. 56.

    Gorman S, Tan DH, Lambert MJ, Scott NM, Judge MA, Hart PH: Vitamin D (3) deficiency enhances allergen-induced lymphocyte responses in a mouse model of allergic airway disease. Pediatr Allergy Immunol. 2012, 23: 83-87. 10.1111/j.1399-3038.2011.01146.x.

    PubMed  Google Scholar 

  57. 57.

    Gupta A, Sjoukes A, Richards D, Banya W, Hawrylowicz C, Bush A, et al.: Relationship between serum vitamin D, disease severity and airway remodeling in children with asthma. Am J Respir Crit Care Med. 2011, 184: 1342-1349. 10.1164/rccm.201107-1239OC.

    PubMed Central  CAS  PubMed  Google Scholar 

  58. 58.

    Jacobs TS, Greenhawt MJ, Hauswirth D, Mitchell L, Green TD: A survey study of index food-related allergic reactions and anaphylaxis management. Pediatr Allergy Immunol. 2012, 23: 582-589. 10.1111/j.1399-3038.2012.01315.x.

    PubMed  Google Scholar 

  59. 59.

    Flammarion S, Santos C, Guimber D, Jouannic L, Thumerelle C, Gottrand F, et al.: Diet and nutritional status of children with food allergies. Pediatr Allergy Immunol. 2011, 22: 161-165. 10.1111/j.1399-3038.2010.01028.x.

    PubMed  Google Scholar 

  60. 60.

    Ball H, Luyt D, Bravin K, Kirk K: Single nut or total nut avoidance in nut allergic children: outcome of nut challenges to guide exclusion diets. Pediatr Allergy Immunol. 2011, 22: 808-812. 10.1111/j.1399-3038.2011.01191.x.

    PubMed  Google Scholar 

  61. 61.

    Brew BK, Kull I, Garden F, Almqvist C, Bergström A, Lind T, et al.: Breastfeeding, asthma, and allergy: a tale of two cities. Pediatr Allergy Immunol. 2012, 23: 75-82. 10.1111/j.1399-3038.2011.01229.x.

    PubMed  Google Scholar 

  62. 62.

    Chuang CH, Hsieh WS, Chen YC, Chang PJ, Hurng BS, Lin SJ, et al.: Infant feeding practices and physician diagnosed atopic dermatitis: a prospective cohort study in Taiwan. Pediatr Allergy Immunol. 2011, 22: 43-49. 10.1111/j.1399-3038.2010.01007.x.

    PubMed  Google Scholar 

  63. 63.

    van de Kant KD, Jansen MA, Klaassen EM, van der Grinten CP, Rijkers GT, Muris JW, et al.: Elevated inflammatory markers at preschool age precede persistent wheezing at school age. Pediatr Allergy Immunol. 2012, 23: 259-264. 10.1111/j.1399-3038.2011.01244.x.

    PubMed  Google Scholar 

  64. 64.

    Ku MS, Sun HL, Sheu JN, Lee HS, Yang SF, Lue KH: Neonatal jaundice is a risk factor for childhood asthma: a retrospective cohort study. Pediatr Allergy Immunol. 2012, 23: 623-628. 10.1111/j.1399-3038.2012.01345.x.

    PubMed  Google Scholar 

  65. 65.

    Sucharew H, Khoury JC, Rao M, Succop P, Bernstein D, Ryan PH, et al.: Predicting allergic disease at age four using an atopy predisposition score at age two: the application of item response theory. Pediatr Allergy Immunol. 2012, 23: 195-201. 10.1111/j.1399-3038.2011.01251.x.

    PubMed Central  PubMed  Google Scholar 

  66. 66.

    Mäkelä MJ, Pelkonen A, Valovirta E, Haahtela T: The challenge of relaying the right public health messages in allergy. Pediatr Allergy Immunol. 2012, 23: 102-10.1111/j.1399-3038.2012.01273.x.

    PubMed  Google Scholar 

  67. 67.

    Apfelbacher CJ, Ollert M, Ring J, Behrendt H, Kramer U: Contact to cat or dog, allergies and parental education. Pediatr Allergy Immunol. 2010, 21: 284-291. 10.1111/j.1399-3038.2009.00893.x.

    PubMed  Google Scholar 

  68. 68.

    Marks GB, Mihrshahi S, Kemp AS, et al.: Prevention of asthma during the first 5 years of life: a randomized controlled trial. J Allergy Clin Immunol. 2006, 118: 53-61. 10.1016/j.jaci.2006.04.004.

    CAS  PubMed  Google Scholar 

  69. 69.

    Maas T, Dompeling E, Muris JW, Wesseling G, Knottnerus JA, van Schayck OC: Prevention of asthma in genetically susceptible children: a multifaceted intervention trial focussed on feasibility in general practice. Pediatr Allergy Immunol. 2011, 22: 794-802. 10.1111/j.1399-3038.2011.01192.x.

    PubMed  Google Scholar 

  70. 70.

    Hicks WB, Nageotte CG, Wegienka G, Havstad S, Johnson CC, Ownby DR, et al.: The association of maternal prenatal IgE and eczema in offspring is restricted to non-atopic mothers. Pediatr Allergy Immunol. 2011, 22: 684-687. 10.1111/j.1399-3038.2011.01160.x.

    PubMed Central  PubMed  Google Scholar 

  71. 71.

    Wen HJ, Wang YJ, Lin YC, Chang CC, Shieh CC, Lung FW, et al.: Prediction of atopic dermatitis in 2-yr-old children by cord blood IgE, genetic polymorphisms in cytokine genes, and maternal mentality during pregnancy. Pediatr Allergy Immunol. 2011, 22: 695-703. 10.1111/j.1399-3038.2011.01177.x.

    PubMed  Google Scholar 

  72. 72.

    Peters RL, Gurrin LC, Allen KJ: The predictive value of skin prick testing for challenge-proven food allergy: a systematic review. Pediatr Allergy Immunol. 2012, 23: 347-352. 10.1111/j.1399-3038.2011.01237.x.

    PubMed  Google Scholar 

  73. 73.

    Zomer-Kooijker K, Slieker MG, Kentie PA, van der Ent CK, Meijer Y: A prediction rule for food challenge outcome in children. Pediatr Allergy Immunol. 2012, 23: 353-359. 10.1111/j.1399-3038.2012.01266.x.

    PubMed  Google Scholar 

  74. 74.

    Caffarelli C, Dondi A, Povesi Dascola C, Ricci G: Skin prick test to foods in childhood atopic eczema: pros and cons. It J Pediatr. 2013, 31: 39-48.

    Google Scholar 

  75. 75.

    Miraglia Del Giudice M, Leonardi S, Maiello N, Brunese FP: Food allergy and probiotics in childhood. J Clin Gastroenterol. 2010, 44: 22-25. 10.1097/MCG.0b013e3181a1bee5.

    Google Scholar 

  76. 76.

    Castellazzi AM, Valsecchi C, Caimmi S, Licari A, Marseglia A, Leoni MC, et al.: Probiotics and food allergy. Ital J Pediatr. 2013, 39: 47-10.1186/1824-7288-39-47.

    PubMed Central  PubMed  Google Scholar 

  77. 77.

    Miraglia Del Giudice M, Leonardi S, Ciprandi G, Galdo F, Gubitosi A, et al.: Probiotics in childhood: allergic illness and respiratory infections. J Clin Gastroenterol. 2012, 46: 69-72.

    Google Scholar 

  78. 78.

    Miraglia Del Giudice M, Maiello N, Decimo F, Fusco N, D’Agostino B, Sullo N, et al.: Airways allergic inflammation and L. reuteri treatment in asthmatic children. J Biol Regul Homeostatic Agents. 2012, 26: 35-40.

    Google Scholar 

  79. 79.

    Ismail IH, Oppedisano F, Joseph SJ, Boyle RJ, Robins-Browne RM, Tang ML: Prenatal administration of lactobacillus rhamnosus has no effect on the diversity of the early infant gut microbiota. Pediatr Allergy Immunol. 2012, 23: 255-8.20. 10.1111/j.1399-3038.2011.01239.x.

    PubMed  Google Scholar 

  80. 80.

    Martín-Muñoz MF, Fortuni M, Caminoa M, Belver T, Quirce S, Caballero T: Anaphylactic reaction to probiotics: cow’s milk and hen’s egg allergens in probiotic compounds. Pediatr Allergy Immunol. 2012, 23: 778-784. 10.1111/j.1399-3038.2012.01338.x.

    PubMed  Google Scholar 

  81. 81.

    Han Y, Kim B, Ban J, Lee J, Kim BJ, Choi BS, et al.: A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis. Pediatr Allergy Immunol. 2012, 23: 667-673. 10.1111/pai.12010.

    PubMed  Google Scholar 

  82. 82.

    Crane J, Lampshire P, Wickens K, Epton M, Siebers R, Ingham T, et al.: Asthma, atopy and exhaled nitric oxide in a cohort of 6-yr-old New Zealand children. Pediatr Allergy Immunol. 2012, 23: 59-64. 10.1111/j.1399-3038.2011.01227.x.

    PubMed  Google Scholar 

  83. 83.

    Kulkarni N, Ragazzo V, Costella S, Piacentini G, Boner A, O’Callaghan C, et al.: Eosinophilic airway inflammation is increased in children with asthma and food allergies. Pediatr Allergy Immunol. 2012, 23: 28-33. 10.1111/j.1399-3038.2011.01226.x.

    PubMed  Google Scholar 

  84. 84.

    Patelis A, Gunnbjornsdottir M, Malinovschi A, Matsson P, Onell A, Hogman M, et al.: Population-based study of multiplexed IgE sensitization in relation to asthma, exhaled nitric oxide, and bronchial responsiveness. J Allergy Clin Immunol. 2012, 130: 397-402. 10.1016/j.jaci.2012.03.046.

    CAS  PubMed  Google Scholar 

  85. 85.

    Gelb AF, Moridzadeh R, Singh DH, Fraser C, George SC: In moderate-to-severe asthma patients monitoring exhaled nitric oxide during exacerbation is not a good predictor of spirometric response to oral corticosteroids. J Allergy Clin Immunol. 2012, 129: 1491-1498. 10.1016/j.jaci.2012.03.036.

    CAS  PubMed  Google Scholar 

  86. 86.

    Vijverberg SJ, Koster ES, Koenderman L, Arets HG, van der Ent CK, Postma DS, et al.: Exhaled NO is a poor marker of asthma control in children with a reported use of asthma medication: a pharmacy-based study. Pediatr Allergy Immunol. 2012, 23: 529-536. 10.1111/j.1399-3038.2012.01279.x.

    PubMed  Google Scholar 

  87. 87.

    Celik M, Tuncer A, Soyer OU, Saçkesen C, Tanju Besler H, Kalayci O: Oxidative stress in the airways of children with asthma and allergic rhinitis. Pediatr Allergy Immunol. 2012, 23: 556-561. 10.1111/j.1399-3038.2012.01294.x.

    PubMed  Google Scholar 

  88. 88.

    Konradsen JR, Nordlund B, Nilsson OB, van Hage M, Nopp A, Hedlin G, et al.: High basophil allergen sensitivity (CD-sens) is associated with severe allergic asthma in children. Pediatr Allergy Immunol. 2012, 23: 376-384. 10.1111/j.1399-3038.2011.01260.x.

    PubMed  Google Scholar 

  89. 89.

    Tosca MA, Silvestri M, Olcese R, Pistorio A, Rossi GA, Ciprandi G: Breathlessness perception assessed by visual analogue scale and lung function in children with asthma: a real-life study. Pediatr Allergy Immunol. 2012, 23: 537-542. 10.1111/j.1399-3038.2012.01316.x.

    PubMed  Google Scholar 

  90. 90.

    Erkoçoğlu M, Akan A, Civelek E, Kan R, Azkur D, Kocabaş CN: Consistency of GINA criteria and childhood asthma control test on the determination of asthma control. Pediatr Allergy Immunol. 2012, 23: 34-39. 10.1111/j.1399-3038.2011.01232.x.

    PubMed  Google Scholar 

  91. 91.

    Barnes PJ: Severe asthma: advances in current management and future therapy. J Allergy Clin Immunol. 2012, 129: 48-59. 10.1016/j.jaci.2011.11.006.

    CAS  PubMed  Google Scholar 

  92. 92.

    Miraglia del Giudice M, Pezzulo A, Capristo C, Alterio E, Caggiano S, De Benedictis D, et al.: Leukotriene modifiers in the treatment of asthma in children. Ther Advances Resp Dis. 2009, 3: 245-251. 10.1177/1753465809348014.

    Google Scholar 

  93. 93.

    Miraglia del Giudice M, Matera MG, Capristo C, Conte M, Santaniello F, Chinellato I, et al.: LABAs in asthmatic children: highlights and new inside. Pulm Pharmacol Ther. 2013, 26: 540-543. 10.1016/j.pupt.2013.04.002.

    CAS  PubMed  Google Scholar 

  94. 94.

    Koutsoubari I, Papaevangelou V, Konstantinou GN, Makrinioti H, Xepapadaki P, Kafetzis D, et al.: Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study. Pediatr Allergy Immunol. 2012, 23: 385-390. 10.1111/j.1399-3038.2012.01280.x.

    PubMed  Google Scholar 

  95. 95.

    Calderon MA, Gerth Van Wijk R, Eichler I, Matricardi PM, Varga EM, Kopp MV, et al.: Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement. Pediatr Allergy Immunol. 2012, 23: 300-306. 10.1111/j.1399-3038.2012.01313.x.

    CAS  PubMed  Google Scholar 

  96. 96.

    Roberts G, Hurley C, Turcanu V, Lack G: Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. J Allergy Clin Immunol. 2006, 117: 263-268. 10.1016/j.jaci.2005.09.054.

    PubMed  Google Scholar 

  97. 97.

    Bufe A, Roberts G: Specific immunotherapy in children. Clin Exp Allergy. 2011, 41: 1256-1262. 10.1111/j.1365-2222.2011.03740.x.

    CAS  PubMed  Google Scholar 

  98. 98.

    Zielen S, Kardos P, Madonini E: Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trial. J Allergy Clin Immunol. 2010, 126: 942-949. 10.1016/j.jaci.2010.06.002.

    CAS  PubMed  Google Scholar 

  99. 99.

    De Swert LF, Gadisseur R, Sjölander S, Raes M, Leus J, Van Hoeyveld E: Secondary soy allergy in children with birch pollen allergy may cause both chronic and acute symptoms. Pediatr Allergy Immunol. 2012, 23: 117-123.

    PubMed  Google Scholar 

  100. 100.

    Pedrosa M, Boyano-Martínez T, García-Ara MC, Caballero T, Quirce S: Peanut seed storage proteins are responsible for clinical reactivity in Spanish peanut-allergic children. Pediatr Allergy Immunol. 2012, 23: 654-659. 10.1111/j.1399-3038.2012.01337.x.

    PubMed  Google Scholar 

  101. 101.

    Ebisawa M, Movérare R, Sato S, Maruyama N, Borres MP, Komata T: Measurement of Ara h 1-, 2-, and 3-specific IgE antibodies is useful in diagnosis of peanut allergy in Japanese children. Pediatr Allergy Immunol. 2012, 23: 573-581. 10.1111/j.1399-3038.2012.01332.x.

    PubMed  Google Scholar 

  102. 102.

    Sverremark-Ekström E, Hultgren EH, Borres MP, Nilsson C: Peanut sensitization during the first 5 yr of life is associated with elevated levels of peanut-specific IgG. Pediatr Allergy Immunol. 2012, 23: 224-229. 10.1111/j.1399-3038.2012.01290.x.

    PubMed  Google Scholar 

  103. 103.

    Savilahti EM, Viljanen M, Kuitunen M, Savilahti E: Cow’s milk and ovalbumin-specific IgG and IgA in children with eczema: low β-lactoglobulin-specific IgG4 levels are associated with cow’s milk allergy. Pediatr Allergy Immunol. 2012, 23: 590-596. 10.1111/j.1399-3038.2012.01277.x.

    PubMed  Google Scholar 

  104. 104.

    Lin SC, Chuang YH, Yang YH, Chiang BL: Decrease in interleukin-21 in children suffering with severe atopic dermatitis. Pediatr Allergy Immunol. 2011, 22 (8): 869-875. 10.1111/j.1399-3038.2011.01209.x.

    PubMed  Google Scholar 

  105. 105.

    Hon KL, Ching GK, Ng PC, Leung TF: Exploring CCL18, eczema severity and atopy. Pediatr Allergy Immunol. 2011, 22: 704-707. 10.1111/j.1399-3038.2011.01174.x.

    PubMed  Google Scholar 

  106. 106.

    Meyer R, Venter C, Fox AT, Shah N: Practical dietary management of protein energy malnutrition in young children with cow’s milk protein allergy. Pediatr Allergy Immunol. 2012, 23: 307-314. 10.1111/j.1399-3038.2012.01265.x.

    PubMed  Google Scholar 

  107. 107.

    van Esch BC, Schouten B, de Kivit S, Hofman GA, Knippels LM, Willemsen LE, et al.: Oral tolerance induction by partially hydrolyzed whey protein in mice is associated with enhanced numbers of Foxp3+ regulatory T-cells in the mesenteric lymph nodes. Pediatr Allergy Immunol. 2011, 22: 820-826. 10.1111/j.1399-3038.2011.01205.x.

    PubMed  Google Scholar 

  108. 108.

    Fuentes-Aparicio V, Alonso-Lebrero E, Zapatero L, Infante S, Lorente R, Angeles Muñoz-Fernández M, et al.: Oral immunotherapy in hen’s egg-allergic children increases a hypo-proliferative subset of CD4+ T cells that could constitute a marker of tolerance achievement. Pediatr Allergy Immunol. 2012, 23: 648-653. 10.1111/j.1399-3038.2012.01333.x.

    PubMed  Google Scholar 

  109. 109.

    Rodríguez Del Río P, Sánchez-García S, Escudero C, Pastor-Vargas C, Sánchez Hernández JJ, Pérez-Rangel I, et al.: Allergy to goat’s and sheep’s milk in a population of cow’s milk-allergic children treated with oral immunotherapy. Pediatr Allergy Immunol. 2012, 23: 128-132. 10.1111/j.1399-3038.2012.01284.x.

    PubMed  Google Scholar 

  110. 110.

    Tripodi S, Comberiati P, Di Rienzo Businco A, Bianchi A, Bondanini F, Sargentini V, et al.: Severe anaphylaxis to sheep's milk cheese in a child desensitized to cow's milk through specific oral tolerance induction. Eur Ann Allergy Clin Immunol. 2013, 45 (2): 56-60.

    CAS  PubMed  Google Scholar 

  111. 111.

    Maiello N, Miraglia Del Giudice M, Capristo C, Decimo F, Santaniello F, Perrone L, et al.: Severe allergic reaction to lactulose in a child with milk allergy. Ann Allergy Asthma Immunol. 2011, 107: 85-10.1016/j.anai.2011.04.001.

    PubMed  Google Scholar 

  112. 112.

    Johnson MJ, Foote KD, Moyses HE, Roberts G: Practices in the prescription of adrenaline autoinjectors. Pediatr Allergy Immunol. 2012, 23: 124-127.

    PubMed  Google Scholar 

  113. 113.

    Calvani M, Berti I, Fiocchi A, Galli E, Giorgio V, Martelli A, et al.: Oral food challenge: safety, adherence to guidelines and predictive value of skin prick testing. Pediatr Allergy Immunol. 2012, 23: 755-761.

    PubMed  Google Scholar 

  114. 114.

    Szefler SJ: Advances in pediatric asthma in 2011: moving forward. J Allergy Clin Immunol. 2012, 129: 60-68. 10.1016/j.jaci.2011.11.011.

    PubMed  Google Scholar 

  115. 115.

    Lu Y, Mak KK, van Bever HP, Ng TP, Mak A, Ho RC: Prevalence of anxiety and depressive symptoms in adolescents with asthma: a meta-analysis and meta-regression. Pediatr Allergy Immunol. 2012, 23: 707-715. 10.1111/pai.12000.

    PubMed  Google Scholar 

  116. 116.

    Meltzer EO, Blaiss MS, Nathan RA, Doherty DE, Murphy KR, Stoloff SW: Asthma burden in the United States: results of the 2009 asthma insight and management survey. Allergy Asthma Proc. 2012, 33: 36-46. 10.2500/aap.2012.33.3543.

    PubMed  Google Scholar 

  117. 117.

    Wassenberg J, Cochard MM, Dunngalvin A, Ballabeni P, Flokstra-de Blok BM, Newman CJ, et al.: Parent perceived quality of life is age-dependent in children with food allergy. Pediatr Allergy Immunol. 2012, 23: 412-419. 10.1111/j.1399-3038.2012.01310.x.

    PubMed  Google Scholar 

  118. 118.

    Stöcklin L, Loss G, von Mutius E, Genuneit J, Horak E, Braun-Fahrländer C, et al.: Health-related quality of life does not explain the protective effect of farming on allergies. Pediatr Allergy Immunol. 2012, 23: 519-521. 10.1111/j.1399-3038.2012.01305.x.

    PubMed  Google Scholar 

  119. 119.

    Vargas PA, Sicherer SH, Christie L, Keaveny M, Noone S, Watkins D, et al.: Developing a food allergy curriculum for parents. Pediatr Allergy Immunol. 2011, 22: 575-582. 10.1111/j.1399-3038.2011.01152.x.

    PubMed Central  PubMed  Google Scholar 

  120. 120.

    Ercan H, Ozen A, Karatepe H, Berber M, Cengizlier R: Primary school teachers’ knowledge about and attitudes toward anaphylaxis. Pediatr Allergy Immunol. 2012, 23: 428-432. 10.1111/j.1399-3038.2012.01307.x.

    PubMed  Google Scholar 

  121. 121.

    Colice GL, Ostrom NK, Geller DE, Anolik R, Blaiss M, Marcus P, et al.: The CHOICE survey: high rates of persistent and uncontrolled asthma in the United States. Ann Allergy Asthma Immunol. 2012, 108: 157-162. 10.1016/j.anai.2011.12.017.

    PubMed  Google Scholar 

  122. 122.

    Arellano FM, Arana A, Wentworth CE, Vidaurre CF, Chipps BE: Prescription patterns for asthma medications in children and adolescents with health care insurance in the United States. Pediatr Allergy Immunol. 2011, 22: 469-476. 10.1111/j.1399-3038.2010.01121.x.

    PubMed  Google Scholar 

  123. 123.

    Caudri D, Wijga AH, Smit HA, Koppelman GH, Kerkhof M, Hoekstra MO, et al.: Asthma symptoms and medication in the PIAMA birth cohort: evidence for under and overtreatment. Pediatr Allergy Immunol. 2011, 22: 652-659. 10.1111/j.1399-3038.2011.01193.x.

    PubMed  Google Scholar 

  124. 124.

    Lodge CJ, Lowe AJ, Gurrin LC, Matheson MC, Balloch A, Axelrad C, et al.: Pets at birth do not increase allergic disease in at-risk children. Clin Exp Allergy. 2012, 42: 1377-1385. 10.1111/j.1365-2222.2012.04032.x.

    CAS  PubMed  Google Scholar 

  125. 125.

    Koster ES, Wijga AH, Koppelman GH, Postma DS, Brunekreef B, De Jongste JC, et al.: Uncontrolled asthma at age 8: the importance of parental perception towards medication. Pediatr Allergy Immunol. 2011, 22: 462-468. 10.1111/j.1399-3038.2011.01150.x.

    PubMed  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Salvatore Tripodi.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

DH wrote the draft version and made the literature search. ST revised the final version. Both authors read and approved the final manuscript.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Cite this article

Hakimeh, D., Tripodi, S. Recent advances on diagnosis and management of childhood asthma and food allergies. Ital J Pediatr 39, 80 (2013).

Download citation


  • Asthma
  • Food allergies
  • Environmental risk factors
  • Parental atopy
  • Guidelines
  • Hygiene hypothesis
  • Infections
  • Management
  • Nutrition
  • Dietary
  • Prediction
  • Prevention
  • Therapy